Company Filing History:
Years Active: 1988-1991
Title: Innovations by William Billard: Advancements in Receptor Activity Measurement
Introduction
William Billard, an inventive mind hailing from Scotch Plains, NJ, has made significant contributions to the field of pharmacology through his innovative patents. With a total of two patents to his name, he has focused on developing methods that enhance the understanding of receptor activities, particularly in relation to anxiolytic drugs and neuroleptic medications.
Latest Patents
His recent inventions include:
1. **Method for measuring the BZ-1 receptor binding activity in a test sample** - This patent describes a method for determining the BZ-1 receptor activity of a test sample or a potential anxiolytic drug. This advancement is pivotal for researchers working on anxiety therapies, as it enables precise measurement of receptor responses.
2. **Assay for D-1 antagonistic activity of neuroleptic drugs** - This invention presents a method, reagents, and kit that facilitate the assessment of D-1 receptor antagonistic activity of neuroleptic drugs. The method leverages the competition between an analyte and tritiated R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol for binding to D-1 receptors in mammalian brain tissue. This patent greatly aids in understanding the effects of neuroleptic drugs on dopamine receptors.
Career Highlights
William Billard is affiliated with Schering Corporation, where he has been instrumental in advancing research and innovation. His focused work on receptor activity measurement aligns well with the company's commitment to developing next-generation therapeutic solutions.
Collaborations
Throughout his career, Billard has worked alongside esteemed colleagues such as Allen Barnett and Louis Iorio. Their collaborative efforts have further strengthened the research initiatives at Schering Corporation, leading to breakthroughs in pharmacological advancements.
Conclusion
William Billard's innovative spirit and dedication to his work have resulted in valuable contributions to the field of pharmacology. His patents not only reflect his expertise but also contribute to the broader understanding of drug interactions and receptor activities, paving the way for future medical advancements.